Injective is back in the spotlight after posting a remarkable 27% surge since last Wednesday, joining a broader market awakening as crypto momentum accelerates. The rally comes as Bitcoin hits new all-time highs and altcoins begin to reclaim critical levels, signaling growing investor confidence across the board. However, it’s not just price action fueling Injective’s breakout. On Friday, Injective announced the launch of the Injective Council—a strategic body composed of influential leaders from Fortune 500 companies and top Web2 organizations. This council marks a pivotal step in their mission to bring real-world adoption to the blockchain. The group will focus on accelerating institutional integration, driving innovation across DeFi, and guiding the platform’s evolution toward global asset tokenization. The announcement was met with optimism from the community and investors alike, who see the council as a sign of serious long-term vision. Injective is positioning itself at the intersection of legacy finance and cutting-edge Web3 infrastructure. Injective: New Era Of Institutional Web3 Integration The project has taken a bold step toward bridging traditional finance and decentralized innovation with the official launch of the Injective Council . This influential body is composed of elite organizations, including Google Cloud, Deutsche Telekom, BitGo, Republic, Galaxy, NTT Digital, and Korea Digital Asset Custody (KDAC). Together, these founding members bring decades of combined institutional, technological, and financial expertise to shape its future. The Council is designed to position Injective as the premier platform where institutional finance converges with Web3 infrastructure. By establishing a formal framework for collaboration, the blockchain team opens the door to meaningful integration between onchain systems and enterprise-grade use cases. Each member will play an active role in steering the protocol’s evolution, providing early insight into Injective’s roadmap while directly shaping priorities and governance decisions. Google Cloud brings scalability and infrastructure expertise to power Injective’s next growth phase. Meanwhile, Galaxy and BitGo contribute critical experience in asset management, custody, and tokenization, helping to build a foundation for real-world financial products like tokenized stocks, credit markets, and structured products. Republic and NTT Digital further broaden the Council’s global reach and regulatory perspective, strengthening Injective’s institutional credibility. The launch of the Injective Council isn’t just a milestone for the protocol—it’s a defining moment for the crypto industry as a whole, signaling that the convergence of traditional finance and blockchain is no longer theoretical. INJ Price Tests Key Resistance Injective (INJ) has shown renewed bullish momentum, gaining over 27% since last Wednesday and closing the latest candle at $12.75. The 3-day chart reveals a clean rebound off the red 200-period moving average, which has provided dynamic support for several weeks. This bounce coincides with a surge in trading volume, signaling increasing investor confidence. INJ is now testing the $12.75–$13 resistance range, a level that previously acted as support during mid-2023 and resistance throughout the second quarter of 2025. A confirmed breakout above this area could open the door for a move toward the 100-period SMA near $16.65, followed by the psychological $20 level. The convergence of all major moving averages (50, 100, 200) above price highlights that INJ remains in a broader bearish structure. If bulls can reclaim the 50-SMA at $11.06 as support and close above $13 with strong volume, the chart structure would favor a mid-term bullish continuation. Featured image from Dall-E, chart from TradingView
